MétaCan
Menu
Back to cohort
Record W4417441229 · doi:10.1016/j.euf.2025.12.007

Harnessing Artificial Intelligence for Risk Stratification and Outcome Prediction in Urologic Cancers: A Systematic Review

2025· review· en· W4417441229 on OpenAlexaff
Navid Roessler, Marcin Miszczyk, Keiichiro Miyajima, Alessandro Dematteis, Ahmed R Alfarhan, Angelo Cormio, Abdulrahman Alqahtani, Tamás Fazekas, Victor M. Schuettfort, Malte W. Vetterlein, Yipeng Hu, Veeru Kasivisvanathan, Constantinos Zamboglou, Michael Leapman, Margit Fisch, Markus Eckstein, Mahul B. Amin, Giovanni Cacciamani, Liang Cheng, Pierre I Karakiewicz, Paweł Rajwa, Shahrokh F. Shariat

Bibliographic record

VenueEuropean Urology Focus · 2025
Typereview
Languageen
FieldMedicine
TopicArtificial Intelligence in Healthcare and Education
Canadian institutionsUniversité de Montréal
FundersEuropean Association of UrologyBoston Scientific CorporationAstellas Pharma US
KeywordsRisk stratificationPersonalizationRisk assessmentMEDLINEProspective cohort study

Abstract

fetched live from OpenAlex

BACKGROUND AND OBJECTIVE: Digital pathology-based artificial intelligence (DP-AI) biomarkers are emerging as transformative tools to guide clinical management of patients affected by various malignancies. We aimed to synthesise current evidence regarding their prognostic and predictive utility in urologic cancers. METHODS: In this prospectively registered systematic review (PROSPERO: CRD420251036536), we searched MEDLINE, Embase, and Web of Science in April 2025 for studies evaluating the prognostic and predictive values of DP-AI models in patients with prostate (PCa), bladder (BCa), renal cell (RCC), testicular (TCa), or penile (PeCa) cancer. The risk of bias was assessed using the Risk of Bias in Non-randomized Studies of Interventions (ROBINS-I) tool. Results were tabulated and summarised qualitatively. KEY FINDINGS AND LIMITATIONS: Of the 1537 screened individual records, we included 31 studies validating DP-AI models in 21 155 patients. Nineteen studies were conducted in PCa (n = 17 541), six in BCa (n = 2349), five in RCC (n = 1176), and one in TCa (n = 89) patients. Ten PCa studies (n = 8951) utilised the ArteraAI model, including two (n = 2786) showing that it allows identification of patients treated with radiotherapy for clinically localised PCa that can safely omit short-term (subdistribution hazard ratio [sHR] 0.34; 95% confidence interval [CI]: 0.19-0.63) or long-term (sHR 0.55; 95% CI: 0.41-0.73) androgen deprivation therapy. Two studies (n = 894) developed and validated a model allowing identification of patients with non-muscle-invasive BCa poorly responding to Bacillus Calmette-Guérin (HR 2.3; 95% CI: 1.9-2.8), including one study (n = 253) validating a predictive biomarker for patients who may benefit from upfront gemcitabine/docetaxel. Many DP-AI models showed a prognostic association in localised PCa (n = 16 863), metastatic PCa (n = 678), non-muscle-invasive BCa (n = 2069), muscle-invasive BCa (n = 280), localised RCC (n = 1176), and germline TCa (n = 89) settings. None of the included studies assessed DP-AI models prospectively. CONCLUSIONS AND CLINICAL IMPLICATIONS: DP-AI biomarkers hold promise to improve treatment personalisation through integration into clinical practice. Prospective validation is now required.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.013
metaresearch head score (Gemma)0.061
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Systematic review · Consensus signal: Systematic review
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.013
Threshold uncertainty score0.067

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0130.061
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0070.008
Bibliometrics0.0080.008
Science and technology studies0.0000.001
Scholarly communication0.0030.002
Open science0.0020.001
Research integrity0.0020.001
Insufficient payload (model declined to judge)0.0030.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.229
GPT teacher head0.455
Teacher spread0.226 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designSystematic review
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations2
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueEuropean Urology FocusSame topicArtificial Intelligence in Healthcare and EducationFrench-language works237,207